Literature DB >> 18216212

Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.

Chao Qi1, Michael Malczynski, Michelle Parker, Marc H Scheetz.   

Abstract

Genotypes of carbapenem-resistant Acinetobacter baumannii collected by the clinical microbiology laboratory of a university hospital in Chicago, IL, between 2004 and 2007 were analyzed by pulsed-field gel electrophoresis. A single genotype established predominance after being introduced in 2005. Analysis of carbapenemases by PCR revealed that imipenem resistance but not meropenem resistance was associated with the presence of bla(OXA-23) and bla(OXA-40) genes.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18216212      PMCID： PMC2268351          DOI： 10.1128/JCM.01877-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 6.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

Review 7.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy.

Authors:  P Villari; L Iacuzio; E A Vozzella; U Bosco
Journal:  Am J Infect Control       Date:  1999-06       Impact factor: 2.918

Review 9.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.

Authors:  G J Da Silva; S Quinteira; E Bértolo; J C Sousa; L Gallego; A Duarte; L Peixe
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790
View more
  20 in total

1.  Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.

Authors:  A F Martins; R Kuchenbecker; T Sukiennik; R Boff; K C Reiter; L Lutz; A B M P Machado; A L Barth
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

2.  Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2.

Authors:  Chia-Ni Lee; Tsai-Tien Tseng; Juey-Wen Lin; Yung-Chieh Fu; Shu-Fen Weng; Yi-Hsiung Tseng
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

3.  Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

Authors:  John S Esterly; Milena Griffith; Chao Qi; Michael Malczynski; Michael J Postelnick; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

4.  Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.

Authors:  Yu-Chi Lin; Ko-Chiang Hsia; Yee-Chun Chen; Wang-Huei Sheng; Shan-Chwen Chang; Mei-Hui Liao; Shu-Ying Li
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

5.  Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.

Authors:  Vijaya Bharathi Srinivasan; Govindan Rajamohan; Wondwossen A Gebreyes
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

6.  Pathogenicity of clinical Acinetobacter baumannii isolates in a Galleria mellonella host model according to bla(OXA-40) gene and epidemiological outbreak status.

Authors:  John S Esterly; Milena M McLaughlin; Michael Malczynski; Chao Qi; Teresa R Zembower; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

7.  Comparative Evaluation of Four Phenotypic Tests for Detection of Metallo-β-Lactamase and Carbapenemase Production in Acinetobacter baumannii.

Authors:  Aparna Shivaprasad; Beena Antony; Poornima Shenoy
Journal:  J Clin Diagn Res       Date:  2014-05-15

8.  Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.

Authors:  Tanya L Johnson; Ursula Waack; Sara Smith; Harry Mobley; Maria Sandkvist
Journal:  J Bacteriol       Date:  2015-12-14       Impact factor: 3.490

Review 9.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

10.  Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA.

Authors:  Vijaya B Srinivasan; Govindan Rajamohan; Preeti Pancholi; Kurt Stevenson; Daniel Tadesse; Prapas Patchanee; Mario Marcon; Wondwossen A Gebreyes
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-17       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.